arrow
A

Andrea Cipriani

psychiatry
H指数:95
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies”, EBioMedicine. 2025 Nov;121:105967. doi: 10.1016/j.ebiom.2025.105967

勘误:发表于EBioMedicine期刊的“用于抑郁症快感缺乏的促多巴胺能药理学干预:一项活体系统评价和网络荟萃分析(涵盖人类和动物研究)”,2025年11月;121:105967。doi: 10.1016/j.ebiom.2025.105967

2025-12-160
OAAI
Mapping the reciprocal interactions between antidepressants and the gut microbiome: novel targets for the personalisation and optimization of drug response

绘制抗抑郁药与肠道微生物组的相互作用的图谱:个性化并优化药物反应的新靶点

2025-11-190
PRE
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis

疗效、全因中止和安全性的评价:5-羟色胺致幻剂和MDMA治疗精神障碍——一项持续更新的系统综述与meta分析

2025-11-070
OAAI
Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies

抗抑郁药物中针对快感缺乏的促多巴胺能药理学干预:一项持续更新的系统综述和网络荟萃分析(基于人类和动物研究)

2025-10-290
OAAI
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis

抗抑郁药对心血管代谢及其他生理参数的影响:一项系统评价和网络Meta分析

2025-10-210
OAAI
Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis

新一代抗抑郁药在儿童和青少年重度抑郁症急性期治疗中的不良反应特征及比较耐受性:一项系统综述和网络meta分析的方案

2025-10-010
PRE
Automating the data extraction process for systematic reviews using GPT-4o and o3

利用GPT-4o和o3实现系统综述数据提取过程的自动化

2025-09-011
OAAI
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission

精神科药物治疗躯体健康不良反应的整体预防与管理:柳叶刀精神病学躯体健康委员会第二次报告

2025-08-120
PRE
Engagement and attrition in digital mental health: current challenges and potential solutions

数字心理健康中的参与度和流失率:当前挑战与潜在解决方案

2025-07-020
OAAI
Personalising Antidepressant Treatment for Unipolar Depression Combining Individual Choices, Risks and big Data: The PETRUSHKA Tool: Personnalisation du traitement antidépresseur de la dépression unipolaire associant choix individuels, risques et mégadonnées: l'outil PETRUSHKA
2025-03-010
PRE
Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis
2024-12-230
PRE